[HTML][HTML] Angiotensin II regulates dendritic cells through activation of NF-κB/p65, ERK1/2 and STAT1 pathways

Y Meng, C Chen, Y Liu, C Tian, HH Li - Cellular Physiology and …, 2017 - karger.com
Background: Activation of dendritic cells (DCs) is necessary to initiate immune responses.
Angiotensin II (Ang II) has been reported to have a proinflammatory and immunomodulatory …

Examining the association of olmesartan and other angiotensin receptor blockers with overall and cause-specific mortality

JW Lin, CH Chang, JL Caffrey, LC Wu, MS Lai - Hypertension, 2014 - Am Heart Assoc
Concerns about an increased cardiovascular risk with the angiotensin receptor blocker,
olmesartan, prompted the current study to examine associations between olmesartan and …

[PDF][PDF] Long term outcomes in patients with heart failure The Darlington Retrospective Out Patient Study (DROPSY)

R Singh - 2014 - etheses.dur.ac.uk
The Darlington Retrospective Outpatient Study (DROPSY) was carried out at the Darlington
Memorial Hospital Darlington. From Jan 2002 to Dec 2007, 1041 patients were seen in the …

STUDI PENGGUNAAN OBAT ACE INHIBITOR PADA PASIEN GAGAL JANTUNG (Penelitian di Poliklinik Jantung dan Vaskular Instalasi Rawat Inap RSUD Dr. Saiful …

NW AGUSDYAH - 2017 - eprints.umm.ac.id
Latar Belakang: Gagal jantung merupakan suatu keadaan akhir dari setiap penyakit
jantung, termasuk aterosklerosis pada arteri koroner, infark miokard, kelainan katup jantung …

[PDF][PDF] Efficacy, Safety and Tolerability of High dose Valsartan Hydrochloride in Essential Hypertension.

MA Zaman - Cardiovascular Journal, 2013 - Citeseer
Background: Studies across the world have demonstrated the efficacy of valsartan in
lowering blood pressure in a variety of patient populations, several of them investigated …